Drug Type Small molecule drug |
Synonyms Ravidasvir/sofosbuvir, Sofosbuvir/ravidasvir, ASC-18 |
Mechanism Hepatitis C virus NS 5 protein inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis C, Chronic | Phase 1 | CN | 12 Apr 2020 |